The Center for Biomedical Research in Infectious Diseases (CIBERINFEC) has again highlighted its involvement in the fight against antibiotic resistance, underscoring that it has a specific scientific program focused on antimicrobial resistance, in which 14 CIBER research groups collaborate.
This message was emphasized on the occasion of the European Day for Prudent Use of Antibiotics, a campaign promoted by the European Centre for Disease Prevention and Control (ECDC) that this year is being rolled out under the slogan "Take care of your children: use antibiotics responsibly".
The 2026 initiative directs attention to the child population, especially infants and preschool-aged children, considered one of the groups with the highest exposure to antibiotic treatments, despite the fact that many common childhood infections do not require antibiotics for their management.
In this context, CIBERINFEC has emphasized its key role in various national and European networks for microbiological surveillance. The team led by the scientific director Jesús Oteo at the CNM-ISCIII coordinates the Network of Laboratories for the Surveillance of Resistant Microorganisms (RedLabRA), integrated into the National Plan against Antibiotic Resistance (PRAN), whose purpose is to have an exhaustive and high-quality microbiological diagnosis, by incorporating genomic sequencing of infection cases caused by antibiotic-resistant bacteria.
This network, supported by the Interterritorial Council of the National Health System, brings together microbiology laboratories from all the autonomous communities, including research staff belonging to 10 CIBERINFEC groups.
Likewise, the participation of the CIBER infectious diseases area in the ECDC’s European strategy against antibiotic resistance is supported by the coordination of the national laboratory sub-networks integrated into the European networks EARS-Net (European Antimicrobial Resistance Surveillance Network), dedicated to surveillance of antimicrobial resistance, and EURGen-Net, oriented to monitoring resistance genes and multiresistant high-risk clones. Both structures are managed at the state level from the CIBERINFEC group led by Jesús Oteo, with the direct involvement of Belén Aracil, María Pérez and Javier Cañada.
"With its scientific and coordination activity, CIBERINFEC contributes to knowledge, surveillance and control of antimicrobial resistance, strengthening national and international efforts to preserve the effectiveness of antibiotics and protect the health of the population", they conclude from the organization.